Literature DB >> 14631101

Molecular-genetic analysis of two cases with retinoblastoma: benefits for disease management.

Govindasamy Kumaramanickavel1, Biju Joseph, Komaravelly Narayana, Sribhargava Natesh, Gandra Mamatha, Mahesh P Shanmugam, Anuradha Elamparathi, Jyotirmay Biswas.   

Abstract

Effective counselling and management of retinoblastoma families using genetic information is presently practised in many parts of the world. We studied histopathological, chromosomal and molecular-genetic data of two retinoblastoma patients from India. The two patients, one with bilateral and the other with unilateral retinoblastoma, underwent complete ophthalmic examination, cytogenetic study, retinoblastoma gene (RB1) mutational analysis and RB1 promoter region methylation screening. In the bilateral retinoblastoma patient deletion of chromosome region 13q14 in peripheral blood lymphocytes and a hemizygous novel 8-bp deletion in exon 4 of RB1 in tumour sample were observed. In the unilaterally affected patient CGA to TGA transition protein truncation mutations were observed in exons 8 and 14 of RB1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14631101     DOI: 10.1007/bf02715880

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  28 in total

1.  Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.

Authors:  E S Knudsen; J Y Wang
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma.

Authors:  D R Lohmann; M Gerick; B Brandt; U Oelschläger; B Lorenz; E Passarge; B Horsthemke
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

3.  Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: Phenotypic and molecular epidemiological implications.

Authors:  J Alonso; P García-Miguel; J Abelairas; M Mendiola; E Sarret; M T Vendrell; A Navajas; A Pestaña
Journal:  Hum Mutat       Date:  2001-05       Impact factor: 4.878

4.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma.

Authors:  W K Cavenee; T P Dryja; R A Phillips; W F Benedict; R Godbout; B L Gallie; A L Murphree; L C Strong; R L White
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

5.  Molecular etiology of low-penetrance retinoblastoma in two pedigrees.

Authors:  T P Dryja; J Rapaport; T L McGee; T M Nork; T L Schwartz
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

6.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation.

Authors:  P L Chen; P Scully; J Y Shew; J Y Wang; W H Lee
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

Review 7.  Developmental basis of retinal-specific induction of cancer by RB mutation.

Authors:  B L Gallie; C Campbell; H Devlin; A Duckett; J A Squire
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

8.  Mutations in the RB1 gene and their effects on transcription.

Authors:  J M Dunn; R A Phillips; X Zhu; A Becker; B L Gallie
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

9.  Overview of RB gene mutations in patients with retinoblastoma. Implications for clinical genetic screening.

Authors:  J W Harbour
Journal:  Ophthalmology       Date:  1998-08       Impact factor: 12.079

10.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

View more
  2 in total

1.  Retinoblastoma: genetic testing versus conventional clinical screening in India.

Authors:  Biju Joseph; Mahesh Palanivelu Shanmugam; Madhuravasal Krishnan Srinivasan; Govindasamy Kumaramanickavel
Journal:  Mol Diagn       Date:  2004

2.  Retinoblastoma genetics screening and clinical management.

Authors:  Himika Gupta; Sivasankar Malaichamy; Ashwin Mallipatna; Sakthivel Murugan; Nallathambi Jeyabalan; Vishnu Suresh Babu; Anuprita Ghosh; Arkasubhra Ghosh; Sam Santhosh; Somasekar Seshagiri; Vedam L Ramprasad; Govindasamy Kumaramanickavel
Journal:  BMC Med Genomics       Date:  2021-07-22       Impact factor: 3.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.